Last reviewed · How we verify

NCT05017220

Nature-based Sensory Stimulation on Pain Levels

Completed NA Last updated 8 October 2021
What this trial tests

NA trial testing Nature-based sensory stimuli in Fibromyalgia in 42 participants. Completed in 31 August 2021.

Timeline
15 July 2021
Primary endpoint
31 August 2021
31 August 2021

Quick facts

Lead sponsorUniversidad de Granada
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment42
Start date15 July 2021
Primary completion31 August 2021
Estimated completion31 August 2021
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Granada — full company profile →

Who can join

Adults 18 to 65, female only, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to evaluate the effect of a single session intervention based on a nature-based stimulation program in patients with fibromyalgia

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Universidad de Granada trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05017220.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing